Influenza

Feature Article

Safety and Efficacy of Intravenous Zanamivir in Severe Influenza

Safety and Efficacy of Intravenous Zanamivir in Severe Influenza

Intravenous zanamivir is as safe and efficacious as oral oseltamivir in hospitalized patients with severe influenza.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Influenza Vaccine Safe During Any Trimester of Pregnancy

Influenza Vaccine Safe During Any Trimester of Pregnancy

Researchers found that the influenza vaccine, when given to pregnant women, does not affect weeks' gestation of the infant at birth or the infant's birth weight.

Intramuscular Flu Vaccination Recommended for Patients With Eczema

Intramuscular Flu Vaccination Recommended for Patients With Eczema

Patients with atopic dermatitis with S aureus had reduced immune response to intradermal influenza vaccination but not intramuscular vaccination.

High-Dose Influenza Vaccine in H3N2 Season More Effective in Seniors

High-Dose Influenza Vaccine in H3N2 Season More Effective in Seniors

Compared to infections by H1N1 or influenza B viruses, H3N2 influenza viruses have been associated with higher mortality in older adults.

Macrophages Play a Role in Protecting Alveolar Epithelial Cells Against IAV

Macrophages Play a Role in Protecting Alveolar Epithelial Cells Against IAV

The cysteinyl leukotriene pathway may be a therapeutic target in future research preventing morbidity associated with severe influenza A virus infection.

Quadrivalent Influenza Vaccine Found to be Safe

Quadrivalent Influenza Vaccine Found to be Safe

No safety signals associated with the administration of quadrivalent live attenuated influenza vaccine were observed, according to a large population study.

CDC Reports on Seasonal Influenza Vaccine Effectiveness

CDC Reports on Seasonal Influenza Vaccine Effectiveness

For the predominant circulating influenza A type H3N2 flu strain, the vaccine effectiveness comes in at 43%.

Double-Dose Influenza Vaccine Safe, Effective in Young Children

Double-Dose Influenza Vaccine Safe, Effective in Young Children

Doubling the standard dose of the inactivated quadrivalent influenza vaccine in children younger than 3 years old had similar efficacy and safety to the standard dose of the vaccine licensed in the United States.

LAIV Safe in Children With Underlying Medical Conditions

LAIV Safe in Children With Underlying Medical Conditions

A CDC study found no significant differences in risks of hospitalization following vaccination with LAIV in children who had underlying illnesses compared to healthy children.

Weekly Influenza Surveillance Report From CDC

Weekly Influenza Surveillance Report From CDC

Map summarizing weekly influenza surveillance report prepared by the CDC's Influenza Division.

Influenza Activity Picks Up Pace Across US

Influenza Activity Picks Up Pace Across US

The most common strain is H3N2, which is contained in the 2016-2017 influenza vaccine.

Sign Up for Free e-newsletters